Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 2/20 | 0.54 |
| ▸ | CES1 | P23141 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TPMT | P51580 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.48 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | VNN1 | O95497 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10697158 | 0.87 | SRD5A2 (0.80) | SRD5A2MAPK1HPGDCES2CES1 | |
| SCHEMBL1681512 | 0.87 | SRD5A2 (0.80) | SRD5A2MAPK1HPGDCES2CES1 | |
| SCHEMBL9065412 | 0.87 | SRD5A2 (0.80) | SRD5A2MAPK1HPGDCES2CES1 | |
| SCHEMBL51827 | 0.87 | SRD5A2 (0.80) | SRD5A2MAPK1HPGDCES2CES1 | |
| SCHEMBL3841301 | 0.87 | TPMT (0.65) | SRD5A2MAPK1HPGDTPMTCA1 | |
| SCHEMBL1244094 | 0.87 | TPMT (0.65) | SRD5A2MAPK1HPGDTPMTCA1 | |
| SCHEMBL9389844 | 0.87 | TPMT (0.65) | SRD5A2MAPK1HPGDTPMTCA1 | |
| Hydrochloric Acid SCHEMBL11704986 | 0.85 | SRD5A2 (0.76) | SRD5A2MAPK1HPGDCES2CES1 | |
| SCHEMBL30010720 | 0.85 | SRD5A2 (0.76) | SRD5A2MAPK1HPGDCES2CES1 | |
| SCHEMBL29985694 | 0.85 | SRD5A2 (0.76) | SRD5A2MAPK1HPGDCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117769458-A | Method for preparing a medium of a substantially monodisperse population of polyarylene ketone or polyarylene sulfide ketone particles, and container comprising said medium | 安捷伦科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117693551-A | Method for preparing porous devices from monodisperse populations of poly aryl ketone or poly aryl thioether ketone particles | 安捷伦科技有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117693542-A | Method for preparing monodisperse populations of poly aryl ketone or poly aryl thioether ketone particles | 安捷伦科技有限公司 | 2024-03-12 | — | — | CN | disclosed |
| US-20230052045-A1 | METHODS OF MAKING POROUS DEVICES FROM MONODISPERSE POPULATIONS OF POLYARYLKETONE OR POLYARYLTHIOETHERKETONE PARTICLES | AGILENT TECHNOLOGIES, INC. (US) | 2023-02-16 | — | — | US | disclosed |
| US-20230051959-A1 | METHODS OF MAKING MONODISPERSE POPULATIONS OF POLYARYLKETONE OR POLYARYLTHIOETHERKETONE PARTICLES | AGILENT TECHNOLOGIES, INC. (US) | 2023-02-16 | — | — | US | disclosed |
| US-20230047460-A1 | METHODS OF MAKING MEDIA OF SUBSTANTIALLY MONODISPERSE POPULATIONS OF POLYARYLKETONE OR POLYARYLTHIOETHERKETONE PARTICLES, AND CONTAINERS COMPRISING THEM | AGILENT TECHNOLOGIES, INC. (US) | 2023-02-16 | — | — | US | disclosed |
| WO-2023009879-A1 | METHODS OF MAKING POROUS DEVICES FROM MONODISPERSE POPULATIONS OF POLYARYLKETONE OR POLYARYLTHIOETHERKETONE PARTICLES | AGILENT TECHNOLOGIES, INC. (US) | 2023-02-02 | — | — | WO | disclosed |
| WO-2023009878-A1 | METHODS OF MAKING MONODISPERSE POPULATIONS OF POLYARYLKETONE OR POLYARYLTHIOETHERKETONE PARTICLES | AGILENT TECHNOLOGIES, INC. (US) | 2023-02-02 | — | — | WO | disclosed |
| WO-2023009880-A1 | METHODS OF MAKING MEDIA OF SUBSTANTIALLY MONODISPERSE POPULATIONS OF POLYARYLKETONE OR POLYARYLTHIOETHERKETONE PARTICLES, AND CONTAINERS COMPRISING THEM | AGILENT TECHNOLOGIES, INC. (US) | 2023-02-02 | — | — | WO | disclosed |
| EP-2937374-B1 | METHOD FOR PRODUCING CYCLIC POLYPHENYLENE ETHER ETHER KETONE COMPOSITION AND LINEAR POLYPHENYLENE ETHER ETHER KETONE, AND METHOD FOR PRODUCING POLYPHENYLENE ETHER ETHER KETONE | TORAY INDUSTRIES (JP) | 2018-06-27 | — | — | EP | disclosed |
| EP-1902032-A1 | PHARMACEUTICAL COMPOUNDS | Astex Therapeutics Limited (GB) | 2008-03-26 | — | — | EP | disclosed |
| CN-1922148-A | Pyrazole derivatives as protein kinase modulators | ASTEX THERAPEUTICS LTD (GB) | 2007-02-28 | — | — | CN | disclosed |
| WO-2006136830-A1 | ARYL-ALKYLAMINES AND HETEROARYL-ALKYLAMINES AS PROTEIN KINASE INHIBITORS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006136821-A1 | PHARMACEUTICAL COMPOUNDS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006136837-A2 | PHARMACEUTICAL COMBINATIONS COMPRISING PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-12-28 | — | — | WO | disclosed |
| EP-1706385-A1 | PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS | Astex Therapeutics Limited (GB) | 2006-10-04 | — | — | EP | disclosed |
| WO-2005061463-A1 | PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS | ASTEX THERAPEUTICS LIMITED (GB) | 2005-07-07 | — | — | WO | disclosed |
| US-6034206-A | POLYANILINES; HEAT, CHEMICAL AND SOLVENT RESISTANCE | TOSOH CORPORATION (JP) | 2000-03-07 | — | — | US | disclosed |
| US-5208259-A | Lipoxygenase enzyme inhibitors | IMPERIAL CHEMICAL INDUSTRIES (GB) | 1993-05-04 | — | — | US | disclosed |
| EP-0409413-A2 | Diaryl ether heterocycles | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230047460-A1 | METHODS OF MAKING MEDIA OF SUBSTANTIALLY MONODISPERSE POPULATIONS OF POLYARYLKETONE OR POLYARYLTHIOETHERKETONE PARTICLES, AND CONTAINERS COMPRISING THEM | TKT, FAH, BCKDK | SRD5A2 1601/4885MAPK1 4111/4885HPGD 1786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.